| Perindopril |
20140022 |
Prinopril, Tablet, 4, mg, Pack: 30 |
Унифарм АД, България |
Унифарм АД, България |
3.49 |
0.7 |
4.19 |
7% |
0.24 |
3.73 |
0.75 |
4.48 |
20% |
0.7 |
4.43 |
0.89 |
5.32 |
|
НСР-3032/21.03.2014 |
08.04.2014 |
08.04.2014 |
Активен |
2617 |
| Measles, mumps and rubella vaccine (live) |
II-3035 / 18.09.2008 г. |
Priorix, Powder and solvent for suspension for injection, 1 dose 0.5 ml, -, Pack: 1 vial with powder + 1 pre-filled syr. 0,5 ml solv + 2 separate needles |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
14.96 |
2.99 |
17.95 |
6% |
0.9 |
15.86 |
3.17 |
19.03 |
18% |
2.69 |
18.55 |
3.71 |
22.26 |
|
КЦРР-718/07.06.2012 |
26.06.2012 |
26.06.2012 |
Активен |
1234 |
| Measles, mumps and rubella vaccine (live) |
9800351 |
Priorix, Powder and solvent for suspension for injection, 1 dose 0.5 ml, -, Pack: 1 vial with powder + 1 ampoule with solvent |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l’Institut 89, 1330 Rixensart, Белгия |
14.67 |
2.93 |
17.6 |
6% |
0.88 |
15.55 |
3.11 |
18.66 |
18% |
2.64 |
18.19 |
3.64 |
21.83 |
|
НСР-7216/15.10.2015. |
30.10.2015 |
30.10.2015 |
Активен |
4084 |
| Measles, mumps and rubella vaccine (live) |
9800351 |
Priorix, Powder and solvent for suspension for injection, 1 dose 0.5 ml, -, Pack: 100 vial with powder + 100 ampoule with solvent |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l’Institut 89, 1330 Rixensart, Белгия |
1550 |
310 |
1860 |
4% |
10 |
1560 |
312 |
1872 |
16% |
25 |
1585 |
317 |
1902 |
|
НСР-8093/17.02.2016. (допуска предварително изпълнение) |
17.02.2016 |
17.02.2016 |
Активен |
4184 |
| Measles, mumps and rubella vaccine (live) |
II-3035/18.09.2008 |
Priorix, Powder and solvent for suspension for injection, Live attenuated measles virus (Schwarz strain) 1; Live attenuated mumps virus (RIT 4385 strain) 1; Live attenuated rubella virus (Wistar RA 27/3 strain) 1, -, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, Belgium |
14.67 |
2.93 |
17.6 |
6% |
0.88 |
15.55 |
3.11 |
18.66 |
18% |
2.64 |
18.19 |
3.64 |
21.83 |
цената се заличава КЦРР-1642/15.11.2012 |
КЦ-1274/29.12.2009 |
17.01.2010 |
17.01.2010 |
Заличен |
855 |
| Measles, mumps and rubella vaccine (live) |
II-3035 / 18.09.2008 г. |
Priorix, Powder and solvent for solution for injection, Live attenuated measles virus (Schwarz strain) 1; Live attenuated mumps virus (RIT 4385 strain) 1; Live attenuated rubella virus (Wistar RA 27/3 strain) 1, mg, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
19.32 |
3.86 |
23.18 |
8% |
1.55 |
20.87 |
4.17 |
25.04 |
20% |
3.86 |
24.73 |
4.95 |
29.68 |
корекционна КЦ-1087/13.08.2009 |
КЦ-704/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
1234 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
372.98 |
74.6 |
447.58 |
4% |
10 |
382.98 |
76.6 |
459.58 |
16% |
25 |
407.98 |
81.6 |
489.58 |
|
НСР-7188/09.10.2015.; НСР-11147/08.12.2016; НСР-15139/02.03.2018 |
17.03.2018 |
02.04.2018 |
Активен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
375.71 |
75.14 |
450.85 |
4% |
10 |
385.71 |
77.14 |
462.85 |
16% |
25 |
410.71 |
82.14 |
492.85 |
|
НСР-7188/09.10.2015.; НСР-11147/08.12.2016 |
24.12.2016 |
02.01.2017 |
Неактивен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
732.95 |
146.59 |
879.54 |
4% |
10 |
742.95 |
148.59 |
891.54 |
16% |
25 |
767.95 |
153.59 |
921.54 |
|
НСР-7189/09.10.2015.; НСР-11148/08.12.2016 г.; НСР-15140/02.03.2018 |
17.03.2018 |
02.04.2018 |
Активен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
752.35 |
150.47 |
902.82 |
4% |
10 |
762.35 |
152.47 |
914.82 |
16% |
25 |
787.35 |
157.47 |
944.82 |
|
НСР-7189/09.10.2015.; НСР-11148/08.12.2016 г. |
24.12.2016 |
02.01.2017 |
Неактивен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
187.43 |
37.49 |
224.92 |
4% |
7.5 |
194.93 |
38.99 |
233.92 |
16% |
25 |
219.93 |
43.99 |
263.92 |
|
НСР-7187/09.10.2015.; НСР-11146/08.12.2016; НСР-15138/02.03.2018 |
17.03.2018 |
02.04.2018 |
Активен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
190.18 |
38.04 |
228.22 |
4% |
7.61 |
197.79 |
39.56 |
237.35 |
16% |
25 |
222.79 |
44.56 |
267.35 |
|
НСР-7187/09.10.2015.; НСР-11146/08.12.2016 |
24.12.2016 |
02.01.2017 |
Неактивен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
759.94 |
151.99 |
911.93 |
4% |
10 |
769.94 |
153.99 |
923.93 |
16% |
25 |
794.94 |
158.99 |
953.93 |
|
НСР-7189/09.10.2015. |
24.10.2015 |
24.10.2015 |
Неактивен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
194.45 |
38.89 |
233.34 |
4% |
7.78 |
202.23 |
40.45 |
242.68 |
16% |
25 |
227.23 |
45.45 |
272.68 |
|
НСР-7187/09.10.2015. |
24.10.2015 |
24.10.2015 |
Неактивен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
379.63 |
75.93 |
455.56 |
4% |
10 |
389.63 |
77.93 |
467.56 |
16% |
25 |
414.63 |
82.93 |
497.56 |
|
НСР-7188/09.10.2015. |
24.10.2015 |
24.10.2015 |
Неактивен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
790.55 |
158.11 |
948.66 |
4% |
10 |
800.55 |
160.11 |
960.66 |
16% |
25 |
825.55 |
165.11 |
990.66 |
|
НСР-155/18.06.2013 |
15.08.2013 |
15.08.2013 |
Неактивен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
197.64 |
39.53 |
237.17 |
4% |
7.91 |
205.55 |
41.11 |
246.66 |
16% |
25 |
230.55 |
46.11 |
276.66 |
|
НСР-154/18.06.2013 |
15.08.2013 |
15.08.2013 |
Неактивен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
395.27 |
79.05 |
474.32 |
4% |
10 |
405.27 |
81.05 |
486.32 |
16% |
25 |
430.27 |
86.05 |
516.32 |
|
НСР-212/20.06.2013 |
15.08.2013 |
15.08.2013 |
Неактивен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
399.97 |
79.99 |
479.96 |
4% |
10 |
409.97 |
81.99 |
491.96 |
16% |
25 |
434.97 |
86.99 |
521.96 |
|
КЦ-2567/15.08.2011 |
30.08.2011 |
30.08.2011 |
Неактивен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
799.93 |
159.99 |
959.92 |
4% |
10 |
809.93 |
161.99 |
971.92 |
16% |
25 |
834.93 |
166.99 |
1001.92 |
|
КЦ-2575/15.08.2011 |
30.08.2011 |
30.08.2011 |
Неактивен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
199.98 |
40 |
239.98 |
4% |
8 |
207.98 |
41.6 |
249.58 |
16% |
25 |
232.98 |
46.6 |
279.58 |
|
КЦ-2482/26.07.2011 |
09.08.2011 |
09.08.2011 |
Неактивен |
2006 |
| Omeprazole |
20100346 |
Probitor, Powder for solution for infusion, 40, mg, Pack: 10 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
37.69 |
7.54 |
45.23 |
4% |
1.51 |
39.2 |
7.84 |
47.04 |
16% |
6.03 |
45.23 |
9.05 |
54.28 |
Протокол № 236/03.08.2017; Промяна на обстоятелства НСР-14758/22.12.2017 |
НСР-6834/30.07.2015. |
14.08.2015 |
02.02.2018 |
Активен |
1862 |
| Omeprazole |
II-9755/2.6.2010 |
Probitor, Powder for solution for infusion, 40, mg, Pack: 10 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
37.69 |
7.54 |
45.23 |
4% |
1.51 |
39.2 |
7.84 |
47.04 |
16% |
6.03 |
45.23 |
9.05 |
54.28 |
Протокол № 236/03.08.2017 |
НСР-6834/30.07.2015. |
14.08.2015 |
02.09.2017 |
Неактивен |
1862 |
| Omeprazole |
II-9755/2.6.2010 |
Probitor, Powder for concentrate for solution for infusion, 40, mg, Pack: 10 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
37.69 |
7.54 |
45.23 |
4% |
1.51 |
39.2 |
7.84 |
47.04 |
16% |
6.03 |
45.23 |
9.05 |
54.28 |
|
НСР-6834/30.07.2015. |
14.08.2015 |
14.08.2015 |
Неактивен |
1862 |
| Omeprazole |
II-9755/2.6.2010 |
Probitor, Powder for concentrate for solution for infusion, 40, mg, Pack: 10 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
37.88 |
7.58 |
45.46 |
4% |
1.52 |
39.4 |
7.88 |
47.28 |
16% |
6.06 |
45.46 |
9.09 |
54.55 |
|
НСР-57/07.06.2013 |
26.06.2013 |
26.06.2013 |
Неактивен |
1862 |